Vera Therapeutics earnings were -$401.9M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest VERA earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$109.5M, down 9.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, VERA reported annual earnings of -$299.6M, with 96.9% growth. The next VERA earnings date is Nov 4, 2026.
What were Vera Therapeutics's earnings last quarter?
On VERA's earnings call on Aug 11, 2026, Vera Therapeutics (NASDAQ: VERA) reported Q2 2026 earnings per share (EPS) of -$1.52, up 26.67% year over year. Total VERA earnings for the quarter were -$109.47 million. In the same quarter last year, Vera Therapeutics's earnings per share (EPS) was -$1.20.
The next VERA earnings call is Nov 4, 2026. Add VERA to your watchlist to be reminded of Vera Therapeutics's next earnings date.
Is Vera Therapeutics profitable or losing money?
As of the last Vera Therapeutics earnings report, Vera Therapeutics is currently losing money. Vera Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$401.90 million, a 84.12% increase year over year.
What was VERA's earnings growth in the past year?
As of Vera Therapeutics's earnings date in Aug 11, 2026, Vera Therapeutics's earnings has grown year over year. VERA earnings in the past year totalled -$401.90 million.
What are Vera Therapeutics's earnings expectations?
The current EPS estimate for Vera Therapeutics's earnings report in Nov 4, 2026 is -$1.72.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.